BioSpace News Archive

Biotech Bay

BioClin Therapeutics to Participate in BTIG Biotech Conference

Dr. Graeme Currie, Ph.D., Chief Operating Officer, will participate in a panel “Targeted Oncology Therapies – Material Advancements, Intriguing Potential” at 1:30 p.m. ET on Thursday, October 25th.

October 22, 2018
·
1 min read
Business

Naveris Congratulates Scientific Advisors Bhisham Chera and Gaorav Gupta on Presentation of Clinical Data at the 2018 ASTRO Annual Meeting

Naveris, Inc., a private biotechnology company developing blood tests for early cancer detection, congratulates Bhisham Chera, M.D. and Gaorav Gupta, M.D., Ph.D.,

October 22, 2018
·
1 min read
Cellect Announces a Major Technological Breakthrough for Industrialization of Apotainer™ Stem Cell Product Line

Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell isolation technology, announced that it has successfully developed for industrialization its first in kind new technology as an integral part of Cellect’s ApoTainer™.

October 22, 2018
·
5 min read
FDA

Eiger BioPharmaceuticals Receives FDA Rare Pediatric Disease (RPD) Designation for Lonafarnib for the Treatment of Progeria and Progeroid Laminopathies and Plans NDA Filing in 2019

Designation Enables Priority Review Voucher Eligibility Upon NDA Approval

October 22, 2018
·
7 min read
Pharm Country

Actinium Pharmaceuticals Announces Webinar Showcasing Actimab-A Post Phase 2 Trial Plans and Actimab-MDS Regulatory Update

Dr. Gary Schiller, Professor of Medicine, Hematology-Oncology at UCLA Medical Center and Dr. Tapan Kadia, Associate Professor of Medicine, at MD Anderson Cancer Center to highlight post Phase 2 development plans for Actimab-A

October 22, 2018
·
8 min read
Pharm Country

New Vitamin Studies Show vitafusion™ is the ONLY Gummy Vitamin with Clinically Proven Absorption, Equal to Traditional Pill Vitamins

Results to Be Unveiled at the Food and Nutrition Conference, October 20-23

October 22, 2018
·
2 min read
Pharm Country

Topcon Healthcare Solutions Announces Clearance of Topcon Harmony

Topcon Harmony is a newly cleared class II medical diagnostic data management software

October 22, 2018
·
2 min read
Business

James Bradley joins Cureatr as Chairman of the Board

Bradley is the former CEO of RxHub - now Surescripts - a healthcare technology company that has developed a nationwide electronic information exchange

October 22, 2018
·
2 min read
Drug Development

Santen Announces Initiation of Phase 3 Clinical Development Program (SPECTRUM) in the United States Evaluating Omidenepag Isopropyl (DE-117) for the Treatment of Glaucoma or Ocular Hypertension

Pivotal Phase 3 development program (SPECTRUM) in the United States, evaluating the investigational use of omidenepag isopropyl (DE-117), a selective agonist for the prostanoid receptor EP2, for the treatment of glaucoma or ocular hypertension (OHT).

October 22, 2018
·
7 min read
Drug Development

Merck KGaA, Darmstadt, Germany, Presents Updated Results for Bifunctional Immunotherapy M7824 at ESMO 2018 Congress

New data include first disclosure of results for M7824 in advanced squamous cell carcinoma of the head and neck, biliary tract cancer and esophageal cancers

October 22, 2018
·
10 min read